Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.72 USD | +1.49% | -2.80% | +31.76% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2.19M | Sales 2025 * | 2.67M | Capitalization | 6.13B |
---|---|---|---|---|---|
Net income 2024 * | -512M | Net income 2025 * | -588M | EV / Sales 2024 * | 2,177 x |
Net cash position 2024 * | 1.37B | Net cash position 2025 * | 846M | EV / Sales 2025 * | 1,982 x |
P/E ratio 2024 * |
-11.9
x | P/E ratio 2025 * |
-10.5
x | Employees | 411 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.97% |
Latest transcript on Revolution Medicines, Inc.
1 day | -0.21% | ||
1 week | -4.81% | ||
Current month | -0.30% | ||
1 month | +3.05% | ||
3 months | +28.17% | ||
6 months | +89.16% | ||
Current year | +29.60% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 18-07-31 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Alexis Borisy
BRD | Director/Board Member | 52 | 14-10-31 |
Sandra Horning
BRD | Director/Board Member | 75 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.05% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 37.77 | +1.61% | 612 093 |
24-05-13 | 37.17 | -0.21% | 1,453,278 |
24-05-10 | 37.25 | -0.53% | 1,013,329 |
24-05-09 | 37.45 | -2.24% | 1,234,702 |
24-05-08 | 38.31 | -1.47% | 916,440 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.60% | 6.13B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+44.13% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- RVMD Stock